Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-03-31

Clinical Trial Update: Microbiome Shift in Peri-mucositis by Anti-inflammatory Drugs [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial is investigating whether anti-inflammatory drugs shift the oral microbiome in peri-implant mucositis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Unspecified anti-inflammatory drugs

Snippet

Sponsor: Polak David | Conditions: Peri-implant Mucositis | EARLY_Phase 1 | Status: UNKNOWN